Check out the companies making headlines before the bell: Oracle — The software giant tumbled more than 12% after reporting fiscal second-quarter revenue that missed analyst expectations. Analysts across Wall Street raced to lower their price targets. Adobe — Shares fell slightly after the software company issued lackluster guidance for fiscal year 2026. Adobe sees earnings per share in a range of $23.30 to $23.50. Analysts polled by FactSet expected a forecast for $23.38 per share. Eli Lilly — A late-stage trial showed the company’s next-generation obesity drug, retatrutide, delivered what appears to be the highest weight loss yet while reducing knee arthritis pain. Shares moved 2% higher. Oxford Industries — The Tommy Bahama and Lilly Pulitzer parent tumbled 21.9% after the apparel maker gave weak current-quarter guidance and cut its full-year earnings outlook. Oxford said to expect between $2.20 and $2.40 in earnings per share, excluding items, in the year, while analysts polled by FactSet penciled in $2.90 per share. Gemini Space Station — Shares jumped 15% after the cryptocurrency exchange secured a license to offer prediction markets to its clients in the U.S. Visa — The payments stock rose 1% after Truist named Visa among its favorite names for 2026, calling it a “preferred quality compounder.” Corbus Pharmaceuticals — The biopharma company gained more than 7% after it reported results from a Phase 1a study that showed a treatment for obesity had a favorable safety profile and emerging evidence of weight loss. Planet Labs — The satellite imagery company surged more than 17% after Planet Labs posted third-quarter revenue of $81 million, which topped the LSEG consensus estimate of $72 million. — CNBC’s Michelle Fox, Alex Harring, Fred Imbert and Liz Napolitano contributed reporting
